Xing-Mao Z, Hong-Juan Z, Qing L, et al. Pancreatic acinar cell carcinoma-case report and literature review. BMC Cancer. 2018;18:1083.

Article  PubMed  PubMed Central  Google Scholar 

Béchade D, Desjardin M, Salmon E, et al. Pancreatic acinar cell carcinoma. Case Rep Gastroenterol. 2016;10:174–80.

Article  PubMed  PubMed Central  Google Scholar 

Glazer ES, Neill KG, Frakes JM, et al. Systematic review and case series report of acinar cell carcinoma of the pancreas. Cancer Control. 2016;23:446–54.

Article  PubMed  Google Scholar 

Sridharan V, Mino-Kenudson M, Cleary JM, et al. Pancreatic acinar cell carcinoma: a multi-center series on clinical characteristics and treatment outcomes. Pancreatology. 2021;21:1119–26.

Article  CAS  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

Article  PubMed  Google Scholar 

Zhou W, Han X, Fang Y, et al. Clinical analysis of acinar cell carcinoma of the pancreas: a single-center experience of 45 consecutive cases. Cancer Control. 2020;27:1073274820969447.

Article  PubMed  PubMed Central  Google Scholar 

Takahashi H, Ikeda M, Shiba S, et al. Multicenter retrospective analysis of chemotherapy for advanced pancreatic acinar cell carcinoma: potential efficacy of platinum- and irinotecan-containing regimens. Pancreas. 2021;50:77–82.

Article  PubMed  Google Scholar 

Wang Y, Wang S, Zhou X, et al. Acinar cell carcinoma: a report of 19 cases with a brief review of the literature. World J Surg Oncol. 2016;14:172.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartwig W, Denneberg M, Bergmann F, et al. Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? Am J Surg. 2011;202:23–7.

Article  PubMed  Google Scholar 

Yoshida N, Kanno A, Masamune A, et al. Pancreatic acinar cell carcinoma with multiple liver metastases effectively treated by S-1 chemotherapy. Intern Med. 2018;57:3529–35.

Article  PubMed  PubMed Central  Google Scholar 

Yoo C, Kim BJ, Kim KP, et al. Efficacy of chemotherapy in patients with unresectable or metastatic pancreatic acinar cell carcinoma: potentially improved efficacy with oxaliplatin-containing regimen. Cancer Res Treat. 2017;49:759–65.

Article  CAS  PubMed  Google Scholar 

Sugimoto M, Hines OJ, Dawson DW, et al. Preoperative treatment with FOLFIRINOX and successful resection for a patient with mixed acinar-endocrine carcinoma of the pancreas. Pancreas. 2017;46:e32–4.

Article  PubMed  PubMed Central  Google Scholar 

Yoshihiro T, Nio K, Tsuchihashi K, et al. Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: a case report. Mol Clin Oncol. 2017;6:866–70.

Article  PubMed  PubMed Central  Google Scholar 

Hashimoto M, Hikichi T, Suzuki T, et al. Successful chemotherapy with modified FOLFIRINOX for pancreatic acinar cell carcinoma. Clin J Gastroenterol. 2017;10:564–9.

Article  PubMed  Google Scholar 

Callata-Carhuapoma HR, Pato Cour E, Garcia-Paredes B, et al. Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature. Pancreatology. 2015;15:440–4.

Article  PubMed  Google Scholar 

Schempf U, Sipos B, König C, et al. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report. Z Gastroenterol. 2014;52:200–3.

Article  CAS  PubMed  Google Scholar 

Di Marco M, Carloni R, De Lorenzo S, et al. Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: a case report. World J Clin Cases. 2020;8:1241–50.

Article  PubMed  PubMed Central  Google Scholar 

Sumiyoshi T, Shima Y, Okabayashi T, et al. Long-term survival following pancreatectomy and S-1 chemotherapy for pancreatic acinar cell carcinoma with peritoneal dissemination: a case report and literature review. Medicine (Baltimore). 2015;94: e378.

Article  PubMed  Google Scholar 

Minakawa K, Oka K, Nihei T, et al. Pancreatic endocrine tumor with partial acinar cell differentiation. APMIS. 2006;114:720–5.

Article  PubMed  Google Scholar 

Martin SK, Agarwal G, Lynch GR. Subcutaneous fat necrosis as the presenting feature of a pancreatic carcinoma: the challenge of differentiating endocrine and acinar pancreatic neoplasms. Pancreas. 2009;38:219–22.

Article  PubMed  Google Scholar 

Ohike N, Kosmahl M, Kloppel G. Mixed acinar-endocrine carcinoma of the pancreas. a clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch. 2004;445:231–5.

Article  PubMed  Google Scholar 

La Rosa S, Adsay V, Albarello L, et al. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers. Am J Surg Pathol. 2012;36:1782–95.

Article  PubMed  Google Scholar 

La Rosa S, Franzi F, Marchet S, et al. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Arch. 2009;454:133–42.

Article  PubMed  Google Scholar 

Hosoda W, Sasaki E, Murakami Y, et al. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens. Pathol Int. 2013;63:176–82.

Article  CAS  PubMed  Google Scholar 

Ide Y, Otsuka T, Shimokawa M, et al. Conversion surgery for unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel. Anticancer Res. 2023;43:1817–26.

Article  CAS  PubMed  Google Scholar 

Furuse J, Shibahara J, Sugiyama M. Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer. J Hepatobiliary Pancreat Sci. 2018;25:261–8.

Article  PubMed  Google Scholar 

Schneitler S, Kropil P, Riemer J, et al. Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection. World J Gastroenterol. 2015;21:6384–90.

Article  PubMed  PubMed Central  Google Scholar